We know from our interactions on Twitter, Facebook and other patient platforms that gynecologic cancer patients and survivors have concerns about risks and questions about how Covid-19 will impact their care. From delaying a port flush or follow-up scan to delaying treatment. Women are also wondering about clinical trial participation in the ever changing Covid-19 environment.
We are excited that the co-chairs of the SGO COVID-19 Task Force - gyn-oncologists Amanda Nickles Fader, MD (@amandanfader), Joshua Kesterson, MD (@KestersonJoshua), and Bhavana Pothuri, MD, MS (@BPothuri), and patient advocate Annie Ellis (@stigetta), will be joining us on Wednesday, April 8, 2020 at 9pm ET.
Please join us as we gather to share about Covid-19 and those impacted by gyn cancers. Bring your questions and share what's on your mind:
- What are your greatest concerns surrounding the Covid-19 pandemic?
- Has Covid-19 impacted your treatment and follow-up care?
- Have you used Telemedicine to communicate with your health care provider?
- Is being a gyn cancer patient/ survivor putting you at increased risk for Covid-19?
- Has clinical trial enrollment / participation been impacted during the Covid-19 outbreak?
- What measures have you taken to reduce the emotional issues related to the Covid-19 outbreak?
- Where can you find the best online support and information available for cancer patients related to Covid-19?
- What can the #gyncsm community do to help patients and healthcare providers through this difficult time?
Dee
#gyncsm Co-Founder
No comments:
Post a Comment